View Daily Data Tracking History
View Bill Text
View Statement of Purpose / Fiscal Impact
H0680......................................................by STATE AFFAIRS
RITALIN - Adds to existing law to require that pharmacists who dispense
Ritalin disclose to the person taking possession of the dispensed
prescription, the potentially addictive nature of the drug and other
current medical information on the effects of use of the drug; to require
written verification of the disclosure; to require that a copy of each such
verification be submitted to the Board of Pharmacy; and to direct the Board
of Pharmacy to promulgate rules to ensure that the disclosed information is
provided by the dispensing pharmacist to each person who takes possession
of a prescription and that specified information be placed on the label of
the dispensed prescription.
02/24 House intro - 1st rdg - to printing
02/25 Rpt prt - to Health/Wel
H0680
|||| LEGISLATURE OF THE STATE OF IDAHO ||||
Fifty-fifth Legislature Second Regular Session - 2000
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 680
BY STATE AFFAIRS COMMITTEE
1 AN ACT
2 RELATING TO UNIFORM CONTROLLED SUBSTANCES; AMENDING CHAPTER 27, TITLE 37,
3 IDAHO CODE, BY THE ADDITION OF A NEW SECTION 37-2731A, IDAHO CODE, TO
4 REQUIRE THAT PHARMACISTS DISPENSING RITALIN SHALL DISCLOSE TO THE PERSON
5 TAKING POSSESSION OF THE DISPENSED PRESCRIPTION THE POTENTIALLY ADDICTIVE
6 NATURE OF THE DRUG AND OTHER CURRENT MEDICAL INFORMATION ON THE EFFECTS OF
7 USE OF THE DRUG, TO REQUIRE WRITTEN VERIFICATION OF THE DISCLOSURE, TO
8 REQUIRE THAT A COPY OF EACH SUCH VERIFICATION BE SUBMITTED TO THE BOARD OF
9 PHARMACY AND TO DIRECT THE BOARD OF PHARMACY TO PROMULGATE RULES TO ENSURE
10 THAT THE DISCLOSED INFORMATION IS PROVIDED BY THE DISPENSING PHARMACIST TO
11 EACH PERSON WHO TAKES POSSESSION OF A PRESCRIPTION AND THAT SPECIFIED
12 INFORMATION IS PLACED ON THE LABEL OF THE PRESCRIPTION.
13 Be It Enacted by the Legislature of the State of Idaho:
14 SECTION 1. That Chapter 27, Title 37, Idaho Code, be, and the same is
15 hereby amended by the addition thereto of a NEW SECTION, to be known and des-
16 ignated as Section 37-2731A, Idaho Code, and to read as follows:
17 37-2731A. DISCLOSURE ON DISPENSING RITALIN. (1) Any pharmacist as
18 defined in section 54-1705(22), Idaho Code, who dispenses the stimulant
19 methylphenidate, commonly known as ritalin, shall disclose, at the least, the
20 following information:
21 (a) As a schedule II drug, it is a controlled uniform substance with a
22 high potential for abuse, and abuse of the drug may lead to severe psychic
23 or physical dependence;
24 (b) Ritalin is chemically similar to cocaine and methamphetamine, carry-
25 ing with it a strong potential for increased tolerance levels and addic-
26 tion;
27 (c) Known side effects of prescriptive use of the drug include
28 tachycardia, dizziness, insomnia, depression, abdominal pain, anorexia,
29 loss of appetite, dry mouth, and suppression of growth has been associated
30 with long-term use;
31 (d) Ingesting the tablet by any means other than swallowing can result in
32 severe reactions or complications such as blood clots, skin and circula-
33 tory problems and even death;
34 (e) Symptoms of overdose may include agitation, confusion, convulsions,
35 delirium, dryness of mucous membranes, enlarging of the pupil of the eye,
36 exaggerated feeling of elation, extremely elevated body temperature,
37 flushing, hallucinations, headache, high blood pressure, irregular or
38 rapid heartbeat, muscle twitching, sweating, tremors or vomiting;
39 (f) No person who takes ritalin after the age of twelve (12) years is
40 eligible for military service; and
41 (g) Distribution of the medication to any other person is a felony
42 offense in Idaho and is also a federal offense.
43 (2) On a form provided by or acceptable to the board of pharmacy, the
2
1 pharmacist shall obtain the signature of each person who takes possession of a
2 prescription verifying that the pharmacist disclosed the information required
3 in subsection (1) of this section.
4 (3) A copy of each signed verification of disclosure shall be submitted
5 to the board of pharmacy within thirty (30) days of the signing. Such com-
6 pleted forms may also be submitted in electronic form.
7 (4) The board is authorized and directed to promulgate rules to ensure
8 that the information in subsection (1) of this section is provided by the
9 dispensing pharmacist to each person who takes possession of a prescription,
10 and the board shall further provide for notation to be placed on the label of
11 the dispensed prescription which states, at a minimum, that:
12 (a) Ingestion of the contents by a person thirteen (13) years of age or
13 older shall render such person ineligible for military service; and
14 (b) It is a federal felony offense and a felony in the state of Idaho to
15 distribute this medication to any person other than the person to whom it
16 has been prescribed.
17 In addition, the board is responsible for ensuring that the information pro-
18 vided by the dispensing pharmacist is consistent with the most current medical
19 findings.
STATEMENT OF PURPOSE
RS 09314C2
The purpose of this legislation is to add additional information to the labeling of
Methylphenidate by a pharmacy.
FISCAL IMPACT
No fiscal impact to the General Fund.
Contact
Name: Rep. John L. Campbell
Phone: 332-1000
STATEMENT OF PURPOSE/FISCAL NOTE H 680